MOUNTAIN VIEW, Calif., Dec. 9, 2010 /PRNewswire/ -- The global scientific community is increasingly recognizing the role of rejuvenation biotechnologies in addressing age-related disease. This week, Arizona-based businessman Jason Hope announced a $500,000 donation to SENS Foundation, a California-based non-profit organization that works to develop, promote and ensure widespread access to rejuvenation biotechnologies which comprehensively address age-related disease.
"I have had great interest in the SENS Foundation and Dr. Aubrey de Grey's work for some time now. I believe their work is essential to the advancement of human medicine and their approach to the overall problem of human aging and its associated diseases (Alzheimer's, Atherosclerosis, Diabetes, etc.) is the only way to go. Their work and the work of others that they support will drive the complete redefinition and reshaping of the healthcare, pharmaceutical, and biotech industries as we know them today. The advancement of rejuvenation biotechnologies is not only extremely important, but it is the future. I am honored to support the SENS Foundation in its efforts, and hope my support helps drive faster results for all of humanity," said Jason Hope.
The donation was announced by SENS Foundation CEO, Mike Kope, at Tuesday's 'Breakthrough Philanthropy' event hosted by the Thiel Foundation, in the Palace of Fine Arts in San Francisco.
"We need to create an entirely new biotech industry. That's why we created SENS Foundation: to be a credible catalyst for change; to be a public research and outreach organization devoted to the creation of a new field- rejuvenation biotechnology. To that end, we are proud that our projects are capturing the imaginations of top tier collaborators in biotech and regenerative medicine. Jason Hope's donation is a major contribution, enabling us to build on our existing collaborations in 2011, and accelerating our progre
|SOURCE SENS Foundation|
Copyright©2010 PR Newswire.
All rights reserved